U.S. federal trademark · Serial No. 86724917
Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases; medical testing for diagnostic or treatment purposes in the field of Huntington's disease; medical testing for diagnostic or treatment purposes in the field of Parkinson's disease; medical testing for diagnostic or treatment purposes in the field of Alzheimer's disease; liquid biopsy testing for medical purposes
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, neurodegenerative diseases; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Huntington's disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Parkinson's disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Alzheimer's disease
Providing clinical laboratory test services for others for scientific research purposes; providing clinical scientific laboratory services for others according to the clinical laboratory improvement amendments (CLIA) program
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.